Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Shukra Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524632NSE Symbol: Not ListedP/E(TTM):112.74
ISIN Demat:INE551C01044Div & Yield %:0.12EPS(TTM):0.19
Book Value(Rs):1.2397304Market Cap ( Cr.):937.94Face Value(Rs):1
    Change Company 
Date Headline
26-Mar-25 Shukra Pharmaceuticals Ltd - Closure of Trading Window
26-Mar-25 Shukra Pharmaceuticals Ltd - Outcome Of Independent Directors Meeting Dated March 26 2025.
20-Mar-25 Shukra Pharmaceuticals Ltd - Corporate Action-Updates on intimation of Sub division / Stock Split
17-Mar-25 Shukra Pharmaceuticals Ltd - Intimation Of New ISIN.
08-Mar-25 Shukra Pharmaceuticals fixes record date for Stock Split
07-Mar-25 Shukra Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
07-Mar-25 Shukra Pharmaceuticals Ltd - Intimation Of Record Date For Sub-Division Of Face Value Of Rs10/- Each To Face Value Of ..
15-Feb-25 Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15-Feb-25 Shukra Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-25 Shukra Pharmaceuticals Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 14Th February 2025 An..
<< < 1 2 3 > >>